nature of clinical laboratory Flashcards

1
Q

Most critical section

A

Blood Bank/Immunohematology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

platelets

A

thrombocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

white blood cells

A

leukocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

red blood cells

A

erythrocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

blood testing for determination of various coagulation factors

A

coagulation studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

enumeration of cells in the blood & other body fluids (eg: CSF, pleural, etc.)

A

Hematology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Identifies bacteria & fungi on specimen

A

Microbiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Testing of blood & other body fluids to

quantify essential soluble chemicals including waste products for the diagnosis of certain diseases

A

clinical chemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

governing affiliation of MT schools, colleges & universities in government hospitals under the DOH

A

AO 247, s. 1976

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

for the accreditation of training labs for MT interns

A

AO 21, s. 1979

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

for the accreditation of clinical labs for training of MT interns

A

AO 118-B, s. 1992

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

revised fees for lab diagnostic procedures performed in the BRL

A

AO 14-A, s. 1997

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

the national policy
on cyto-screening in cervical cancer
control program designation of MTs as
cyto-screeners

A

AO 19-A, s. 1998

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

the national policy
on cyto-screening in cervical cancer
control program designation of MTs as
cyto-screeners

A

AO 19-A, s. 1998

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
decentralization of
some regulatory functions of the
Bureau of Health Facilities and
Services on Clinical Laboratories & HIV
testing labs to the centers for health
development in the transition phase
A

AO 7-C, s. 2001

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NS1-Ag for dengue

A

Immunology & serology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

the national policy
on cyto-screening in cervical cancer
control program designation of MTs as
cyto-screeners

A

AO 19-A, s. 1998

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
decentralization of
some regulatory functions of the
Bureau of Health Facilities and
Services on Clinical Laboratories & HIV
testing labs to the centers for health
development in the transition phase
A

AO 7-C, s. 2001

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

NS1-Ag for dengue

A

Immunology & serology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

rapid plasma reagin

A

Immunology & serology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

treponema pallidum
particle agglutination
tests

A

Immunology & serology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

differential staining

techniques

A

Microbiology, bacteriology, &

mycology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

culture & identification of
bacteria & fungi from
specimens

A

Microbiology, bacteriology, &

mycology

24
Q

antimicrobial

susceptibility testing

A

Microbiology, bacteriology, &

mycology

25
Q

clinical enzymology

A

Special clinical chemistry

26
Q

markers for certain

diseases

A

Special clinical chemistry

27
Q

therapeutic drug

monitoring

A

Special clinical chemistry

28
Q

bone marrow studies

A

Special hematology

29
Q

special staining for

abnormal cells

A

Special hematology

30
Q

red cell orphology

A

Special hematology

31
Q

blood donation program

A

Immunohematology & blood

banking

32
Q

antibody screening &

identification

A

Immunohematology & blood

banking

33
Q

preparation of blood

components

A

Immunohematology & blood

banking

34
Q

lab in a government hospital
designated by the DOH to provide
special diagnostic functions &
services for certain diseases

A

National Reference Laboratory

35
Q

perform all lab tests in secondary category plus:

A

Tertiary Category

36
Q

perform lab tests done by the primary category with routine clinical chemistry tests

A

Secondary category

37
Q

perform basic routine lab testing

A

Primary category

38
Q

owned, established &
operated by an individual,
corporation, institution, association,
or organization

A

Privately

39
Q

owned,
wholly/partially, by national/local
government units (usually by DOH)

A

Government

40
Q

operates within the premises or part

of an institution

A

Institution based/Hospital-based

41
Q

microscopic examination of tissues &

organs

A

Anatomical Pathology

42
Q

testing of

blood & other bodily fluids

A

Clinical Pathology

43
Q
“Rules and Regulation
Governing the Establishment,
Operation, and Maintenance of
Clinical Laboratories in the
Philippines”
A

Section 1: Title

44
Q

CLINICAL LABORATORY LAWS

A

RA 4688

JUNE 18, 1966

45
Q
• Implements RA 4688
• DOH, through the Bureau of
Health Facilities and Services
(BHFS) shall exercise the
regulatory functions under
these rules & regulations
A

Section 2: Authority

46
Q
To protect & promote health of
the people by ensuring
availability of clinical labs that
are properly managed with
adequate resources, with
effective & efficient
performance through
compliance with quality
standards
A

Section 3: Purpose

47
Q
  • Apply to all entities performing the activities & functions of clinical labs (analysis & examination of all samples of human tissues & body fluids)
  • except for government labs doing lab examinations limited to acid fast bacilli microscopy, malaria screening & cervical cancer screening
A

Section 4: Scope

48
Q
• Permit to construct is given by
BHFS prior to submission of
Petition to Operate
• license to operate is issued by
BHFS/CHD
A

Section 6: Policies

49
Q

• Inspection shall be done by director of BHFS/CHD every two years or as necessary

A

Section 7: Requirements &
Procedures for Application of Permit
to Construct & License to Operate

50
Q
• Operation of a clinical lab
without a certified pathologist or
registered MT
• change of ownership, location,
head of laboratory or personnel
without informing the
BHFS/CHD
• refusal to allow inspection of the
clinical lab by the person/s
authorized by the BHFS during
reasonable hours
• gross negligence
• any act/omission detrimental to
the public
A

Section 8: Violations

51
Q
• Done by BHFS/CHD
• violation of RA 4688 will mean
suspension, cancelation or
revocation of the license as well
as the authority of the offending
person/s
• operation without proper license
shall be subjected to
imprisonment for 1 month - 1
year, or fine of P1000.00 -
P5000.00, or both
A

Section 9: Investigation of

Charges/Complaints

52
Q
• A license may be revoked,
suspended or modified in full or
in part for any material false
statement by the applicant, or
as shown by the record of
inspection or for a violation of,
or failure to comply any of the
terms and conditions &
provisions of these rules &
regulations.
A

Section 10: Modification &

Revocation of License

53
Q

Rules & regulations shall
supersede all other previous
official issuance hereof.

A

Section 11: Repealing Clause

54
Q

A list of licensed clinical labs
must be published annually in a
newspaper or general
circulation.

A

Section 12: Publication of List of

Licensed Clinical Labs

55
Q

Rules & regulations shall take
effect 15 days after its
publication in a newspaper or
general circulation.

A

Section 13: Effectivity